Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 8-K (Current Report)
Reporting Period: First Quarter ended March 31, 1999
Report Date: April 27, 1999
DuPont reported first-quarter earnings while announcing significant strategic actions to transform its portfolio, including the acquisition of Herberts (automotive coatings) and an agreement to purchase the remaining 80% of Pioneer Hi-Bred International. The company also announced intentions to issue a tracking stock for life science businesses and form joint ventures for its Polyester Enterprise.
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 |
|---|---|---|
| Sales | $6,295 million | $6,194 million |
| Income from Continuing Operations | $628 million | $637 million |
| Underlying Income (Excl. Nonrecurring) | $749 million | $782 million |
| Net Income | $663 million | $906 million |
| Diluted EPS (Continuing Ops) | $0.66 | $0.68 |
| Diluted EPS (Total) | $0.58 | $0.79 |
| Dividends Per Share | $0.35 | $0.315 |
Cash Flow, Debt, and Liquidity: The filing text does not provide specific values for operating cash flow, total debt, or liquidity ratios. The report focuses on earnings and segment operating income.
Material Changes vs. Prior Period
- Sales Growth: Sales increased 2% to $6.3 billion. Volume increased 4% (including acquisitions), while average prices decreased 2%.
- Discontinued Operations: Income from discontinued operations (Conoco) plummeted 87% to $35 million from $269 million, driven by a 20%+ decline in oil and gas prices and reduced ownership interest.
- Nonrecurring Items: Q1 1999 included $121 million in net charges, primarily related to the Herberts acquisition (purchased in-process R&D and exchange losses). Q1 1998 included $145 million in charges related to PTI acquisition revisions and nylon modernization.
- Segment Performance:
- Pharmaceuticals: Earnings up 50% ($75M vs $50M) and sales up 88%, reflecting 100% ownership consolidation.
- Nylon Enterprise: Earnings up 13% despite a 6% sales decline, aided by lower raw material costs.
- Polyester Enterprise: Reported a loss of $6 million (vs $4 million profit) due to overcapacity and price pressure.
- Specialty Fibers: Earnings down 4% due to lower Lycra earnings.
Guidance, Outlook, and Risks
Management Commentary: CEO Charles O. Holliday stated that 1999 could be "slightly stronger than expected" based on Q1 results. Management expressed confidence in returning to double-digit earnings growth in 1999 (next year).
Strategic Outlook: The company is actively shifting toward higher growth businesses (Life Sciences, Pharmaceuticals) and repositioning mature businesses through alliances and divestitures.
Risks and Contingencies:
- Forward-looking statements are subject to risks including changes in laws, regulations, and economic conditions.
- Competitive pressures and the successful integration of structural changes (acquisitions/divestitures).
- Year 2000 compliance risks for the company and third parties.
- Regulatory approval and market acceptance for new R&D products.
Investor Verification Checklist
- Herberts Acquisition Accounting: Verify the final purchase price allocation and the impact of the $40 million preliminary charge for in-process R&D.
- Conoco Divestiture: Confirm the timeline and financial impact of the remaining ownership reduction in the energy subsidiary.
- Polyester Turnaround: Assess the progress and financial impact of the announced joint ventures with Teijin, Sabanci Holding, and Alpek.
- Pharmaceutical Consolidation: Review the sustainability of the 50% earnings increase driven by full consolidation of the pharmaceutical business.
- Year 2000 Compliance: Evaluate the status of IT system upgrades to mitigate the stated risk of failure to become Year 2000 capable.